Sarah Mirando  |  March 6, 2013

Category: Pharmaceuticals

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Follow us on Twitter and Facebook for the latest Stevens Johnson Syndrome (SJS) Class Action Lawsuit News!
 

New Epilepsy Drugs Could Reduce Stevens Johnson Syndrome Risk

By John Curran

 

Stevens Johnson Syndrome lawsuitDilantin and Lamictal, with chemical names of phenytoin and lamotrigine respectively, are two popular options for epilepsy treatment that many doctors opt for because of their cost. Both have been on the market for years and both are now generic. Yet both also carry Stevens Johnson Syndrome concerns, which is why a new market research report on epilepsy treatments may be significant.

Decision Resources says that by 2016, the epilepsy drug market will increase by more than 25 percent, but the uptick is based on the usage of newer, so-called third-generation drugs. While ones like Vimpat are still linked to Stevens Johnson Syndrome, the risk may not be so high for epilepsy treatment. Also, even if the autoimmune disease occurs with Dilantin or Lamictal, a new treatment would allow patients to continue limiting their risk of seizures via medication with less potential for relapse.

Unfortunately, nearly all anti-epileptic drugs carry some risks for Stevens Johnson Syndrome, as do nearly all medications – including over-the-counter drugs like ibuprofen. As noted in previous articles, one way to minimize this is by limiting the use of drugs except for truly necessary cases, such as waiting to see if a fever will pass. Even for those with epilepsy, there are other options for treatment that include drugs, including minor brain surgery to excise affected portions of the organ.

Still, many people will take drugs and not notice that drug safety packets include mentions of any potential rash. Some of these are caused by an allergy to the medication, which may or may not be dangerous. However, symptoms of potential Stevens Johnson Syndrome are not generally listed on most packets. They include a rash on the extremities and both fever and chills.

Rapid treatment is critical as the autoimmune condition can lead to inflamed or dead skin in the case of the more advanced form, toxic epidermal necrolysis. In addition, since it attacks mucus membranes, many victims of Stevens Johnson Syndrome go blind as a result.

If you believe that a medication caused toxic epidermal necrolysis or a similar condition, consider a free legal consultation to see whether or not to file a case against the drug maker. One is available by filling out the short form at the Stevens Johnson (SJS) & Toxic Epidermal Necrolysis (TEN) Class Action Lawsuit Investigation. These are painful conditions, but a legal remedy could defray the costs of treatment.

 

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

Updated March 6th, 2013

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2013 Top Class Actions® LLC
Various Trademarks held by their respective owners.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.